AU2020904616A0 - Formulations for Delivery of Bioactive Agents - Google Patents

Formulations for Delivery of Bioactive Agents

Info

Publication number
AU2020904616A0
AU2020904616A0 AU2020904616A AU2020904616A AU2020904616A0 AU 2020904616 A0 AU2020904616 A0 AU 2020904616A0 AU 2020904616 A AU2020904616 A AU 2020904616A AU 2020904616 A AU2020904616 A AU 2020904616A AU 2020904616 A0 AU2020904616 A0 AU 2020904616A0
Authority
AU
Australia
Prior art keywords
formulations
delivery
bioactive agents
bioactive
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020904616A
Inventor
Taghrid Istivan
Stefan Kasapis
Nazim Nassar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RMIT University
Original Assignee
Royal Melbourne Institute of Technology Ltd
Filing date
Publication date
Application filed by Royal Melbourne Institute of Technology Ltd filed Critical Royal Melbourne Institute of Technology Ltd
Publication of AU2020904616A0 publication Critical patent/AU2020904616A0/en
Priority to US18/266,064 priority Critical patent/US20240024234A1/en
Priority to AU2021394122A priority patent/AU2021394122A1/en
Priority to PCT/AU2021/051477 priority patent/WO2022120435A1/en
Priority to JP2023535451A priority patent/JP2023552478A/en
Priority to EP21901721.7A priority patent/EP4259713A1/en
Priority to CN202180093262.5A priority patent/CN116867852A/en
Abandoned legal-status Critical Current

Links

AU2020904616A 2020-12-11 2020-12-11 Formulations for Delivery of Bioactive Agents Abandoned AU2020904616A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US18/266,064 US20240024234A1 (en) 2020-12-11 2021-12-10 Formulations for Delivery of Bioactive Agents
AU2021394122A AU2021394122A1 (en) 2020-12-11 2021-12-10 Formulations for delivery of bioactive agents
PCT/AU2021/051477 WO2022120435A1 (en) 2020-12-11 2021-12-10 Formulations for delivery of bioactive agents
JP2023535451A JP2023552478A (en) 2020-12-11 2021-12-10 Formulations for the delivery of bioactive agents
EP21901721.7A EP4259713A1 (en) 2020-12-11 2021-12-10 Formulations for delivery of bioactive agents
CN202180093262.5A CN116867852A (en) 2020-12-11 2021-12-10 Formulations for delivery of bioactive agents

Publications (1)

Publication Number Publication Date
AU2020904616A0 true AU2020904616A0 (en) 2020-12-24

Family

ID=

Similar Documents

Publication Publication Date Title
IL291219A (en) Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
IL291375A (en) Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents
IL291339A (en) Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents
AU2016343803A8 (en) Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
EP3914252A4 (en) Pharmaceutical compositions of nilotinib
EP4058190A4 (en) Compositions and methods for controlled delivery and protection of therapeutic agents
EP3917528A4 (en) Phlip® targeted delivery of potent cytotoxic compounds
EP4117684A4 (en) Compositions and methods for enhanced delivery of antiviral agents
EP3500291A4 (en) Formulations for oral administration of active agents
EP3937905A4 (en) Rinse-off compositions and uses thereof for delivery of active agents
EP3768829A4 (en) Formulations for improving the delivery of hydrophobic agents
EP4037740A4 (en) Acoustic nebuliser for delivery of active agents
EP3773747A4 (en) Use of exosomes for targeted delivery of therapeutic agents
EP4166155A4 (en) Composition comprising pentapeptide as active ingredient
EP4021369A4 (en) Medical devices for continuous delivery of therapeutic agents
EP4099999A4 (en) Formulations of docetaxel
AU2020904616A0 (en) Formulations for Delivery of Bioactive Agents
EP3956429A4 (en) Active composition delivery system
EP3895719A4 (en) Pharmaceutical composition comprising lactobacillus sakei wikim30 as active ingredient for prevention or treatment of cancer
EP3654950A4 (en) Microparticle formulations for delivery of active agents
EP3743072A4 (en) Pharmaceutical composition for sustained release delivery of buprenorphine
EP4097237A4 (en) Nuclease-scaffold composition delivery platform
IL291283A (en) Drug delivery formulations
AU2020901302A0 (en) Formulation for inhalation delivery of pharmaceutical agents
GB202203127D0 (en) Aerosolised formulation